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The incidence of oral squamous cell carcinoma (SCC) has
increased over the past decades in Europe and in the United States.
At the same time, mortality from the disease has increased as well
(Depue, 1986; Davis and Severson, 1987; Macfarlane et al, 1996).
The management of oral SCC is notably dependent on the TNM
staging system, which is based on the clinical evaluation. The
stage, however, is not always sufficient for prognostication. For
example, some small T1 tumours behave in an aggressive manner
and have an unexpectedly poor prognosis. Thus, it would be of
great benefit to be able to identify the more aggressive tumours at
the time of diagnosis. There are numerous previous publications
dealing with the identification of demographic, clinical and
histological prognostic factors (Janot et al, 1996; Gluckman et al,
1997). However, apart from TNM stage, there is controversy over
the relative importance of different prognostic factors.
Since the TNM stage has been found to be the most important
prognostic factor for oral SCC, there are studies of specifically
TNM stage I tumours (Högmo et al, 1999) or T1–2 tumours
(Leedy et al, 1994), for example. Nevertheless, to our knowledge,
there are no previous studies in which the prognostic factors would
have been compared in all stages. The aim of the present paper
was to assess the relative importance of the known prognostic
demographic, clinical and histological factors in a population-
based sample of 105 patients with SCC of the mobile tongue.
Furthermore, we investigated whether distinctive prognostic




The study area comprised the two northernmost provinces of
Finland with a population of approximately 700 000. The Oulu
University Hospital is the only tertiary centre in the area, and all
the patients with tongue cancer are treated there. All the patients
who lived in the area and were diagnosed with cancer of the
tongue (International Classification of Diseases, version 9, code
141) between January 1st 1974 and December 31st 1994 were
manually identified from the surgical, radiotherapy and discharge
registers of the Oulu University Hospital. Carcinomas extending
over various anatomical structures were included, whenever the
tongue was clinically and without a doubt detected to be the site 
of origin. Tumours of the base of the tongue (International
Classification of Diseases, version 9, code 1410) were excluded
from the study. Altogether 108 new cases of tongue cancer were
detected during the period 1974–1994. Three cases were excluded
because of insufficient clinical data.
Demographic factors
Data concerning the following demographic factors were gathered
from the clinical records: sex, age at the time of diagnosis (44
years or under, 45–65 years and over 65 years), socio-economic
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aLast two authors have equally contributed to the work.status (United Nations, 1978), place of residence (urban vs. rural)
(Statistics Finland, 1993), smoking (current or former smoker vs.
non-smoker) and alcohol consumption (none, light, moderate vs.
heavy). Alcohol consumption was defined as heavy if the patient
drank daily or he/she had been diagnosed as an alcoholic.
Clinical factors
The following clinical factors were gathered from the patient’s
primary care or hospital files: clinical appearance of the carcinoma
(exophytic vs. indurated, ulcerative, crater), carcinoma spread
outside the tongue (yes vs. no), neck nodes at the time of diagnosis
(yes vs. no), and the TNM stage classification of the tumour
(International Union Against Cancer, 1987).
Histopathological factors
All the histological factors were determined from paraffin sections
of pre-treatment biopsies. Eight cases were excluded because of
poor specimen quality. During the study, unfortunately, several
paraffin blocks were exhausted, and only 55 samples were avail-
able for analysis of apoptosis. The histological sections (with the
exception of WHO grading) were analysed by two of the authors
suitably trained in scoring. The determination was done in a
blinded manner without a knowledge of the patient outcome. The
scores were based on consensus between the two authors. The
following factors were determined from the sections.
Tumour grade according to the WHO classification (well differ-
entiated, moderately differentiated or poorly differentiated, World
Health Organization, 1997), as given by the pathologist, was retro-
spectively reviewed from the patients’ hospital files. The malig-
nancy scores of the carcinomas were determined using the method
introduced by Bryne et al (1992). In this method, the score is deter-
mined from the deep invasive tumour margins. We determined the
score from the most lateral invasive margin of the tumour present
on the sample, as the deep invasive margin of the tumour was only
present in 26 (29%) of the biopsy samples. A score from 1 to 4 is
given for five morphological features: degree of keratinization,
nuclear polymorphism, number of mitoses, pattern of invasion and
lymphoplasmacytic infiltration. The subscores are then summed
up into a total malignancy score (5–20). In the analysis, the cases
were divided into three groups based on the malignancy score:
5–10 points, 11–15 points and 16–20 points.
Tumour angiogenesis was determined from sections immuno-
histochemically stained against factor VIII (Dako, A/S, Glostrup,
Denmark), the method used being similar to that of Leedy et al
(1994). The microvessels, excluding single cells, were counted in
ten high-power fields within the tumour (objective × 40; diameter of
the field 400 µ m). The mean value of the vessels in the ten fields
was counted, and the results were divided into three groups based on
the quartiles of the means for the analysis of tumour angiogenesis.
Inflammatory cells (polymorphonuclear, neutrophilic and
eosinophilic leucocytes, lymphocytes and plasma cells) were
counted on the tumour margin (objective × 40, diameter of the
field 400 µ m). The total extent of the inflammatory infiltrate was
categorised as light (+), moderate (++) or heavy (+++).
Nerve invasion was determined by using S-100-stained sections
(Dako, A/S, Glostrup, Denmark). Nerve invasion was considered
positive if there were clearly recognisable SCC cells in any of the
nerves present in the biopsy section.
To determine tumour apoptosis, 3′ -end labelling of apoptotic
cell DNA was performed using the ApopTag® in situ apoptosis
detection kit (Oncor, Gaithersburg, MD) and following the manu-
facturer’s instructions with a few modifications as described by
Soini and Pääkkö (1996). Apoptotic cells were counted using a
similar method as applied to microvessels. For the analysis of
apoptosis, the results were divided into three groups based on the
quartiles of the means.
The presence of human papilloma virus DNA (HPV 6, 11, 16,
18, 31 and 33 subtypes) in the sections was ascertained by in situ
hybridization as described by Soini et al (1996). Human papilloma
virus was also detected by PCR, using the HPV consensus primers
MY 09 and MY 11 (Soini et al, 1996), β -actin by 5′ sense and 3′
antisense primers according to Ponte et al (1984).
Overexpression of p53 protein was determined from sections
using similar method as described by Soini and Pääkkö (1996).
Immunohistochemical staining was done using the polyclonal
rabbit anti-human p53 antibody CM1 diluted 1:1000 and the
secondary anti-rabbit antibody as well as the avidin-biotin
peroxidase complex (Vectastain® ABC kit, Vector laboratories,
Burlingame, CA). The expression of p53 was recorded as negative
(–), weakly positive (+) or strongly positive (++).
Treatment of patients
Small T1N0M0 carcinomas were treated with local radical surgery
without neck dissection. In the case of T2N0M0 carcinomas,
modified upper neck dissection was included in the treatment.
Larger and more widely spread carcinomas were treated with a
combination of hemiglossectomy and radical neck dissection and
adjacent postoperative radiotherapy. The most advanced, inoper-
able cases were treated with radiotherapy only. Sixty-six (63%) of
the patients had surgery, 20 (19%) radiotherapy and 11 (10%) both
surgery and adjuvant radiotherapy. Five (5%) of the patients
refused surgery and were thus treated with radiotherapy alone, and
three (3%) patients did not receive any treatment.
Statistical methods
The inter-relationships between the various prognostic factors
were assessed with the chi-square method. The overall and
disease-specific mean survival and recurrence-free times and their
95% confidence intervals (95% CI) were calculated according 
to the Kaplan-Meier method. Furthermore, disease-specific 75th
percentile survival times and their ranges were calculated and
compared with Breslow’s test. The disease-specific survival time
was determined from the date the patient first received treatment
for the cancer. The tumour status of each patient was recorded
based on the data of the latest control visit at the referral centre.
The prognostic effects of demographic and histopathological
factors were studied separately in stage I–II and stage III–IV




The mean overall survival time was 99 months (95% CI 80–118)
and the disease-specific survival time 145 months (95% 
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was 19 months (range 2, 91). A total of 42 (40%) patients devel-
oped a recurrence during the follow-up. The mean recurrence-free
rate was 126 months (95% CI 105–148). The recurrences were
local in 47% of the cases, in the neck in 35% and both local and in
the neck in 18%.
Distributions and prognostic effects of demographic,
clinical and histopathological factors in univariate
analyses
Sixty (55%) of the patients were female (Table 1). The median age
of the patients was 64 years (range 26–90). Seventy-seven percent
of the patients had a low socio-economic status and 65% lived in
an urban domicile. Over half of the patients were smokers and
22% were heavy alcohol users. The patient’s older age and heavy
use of alcohol decreased significantly the disease-specific survival
time (P values 0.02 and 0.05, respectively). None of the other
demographic factors had a significant effect on survival (Table 1).
There were 44 (44%) stage I–II carcinomas in the study, and in
forty-three (41%) cases the carcinoma had spread to the neck
nodes by the time of diagnosis (Table 2). The median size of the
carcinomas was 30 m. The TNM stage had the most significant
effect on the patient’s mean disease-specific survival time (P =
0.0001) (Table 2). Particularly local spread outside the tongue had
a significant effect on prognosis (P = 0.04). Tumour size, the pres-
ence of positive neck nodes at the time of diagnosis or the clinical
appearance of the carcinoma did not have a statistically significant
effect on disease-specific survival (Table 2).
Three (3%) of the patients had a poorly differentiated neoplasm
(Table 3). Only five (6%) of the cases had a high (16–20 points)
malignancy score. None of the histopathological factors had a
statistically significant effect on disease-specific survival 
(Table 3). Nevertheless, a low malignancy score and a heavy
tumour angiogenesis (mean of 8.5 vessels or over) tended to have
a positive influence on survival time. Also, when there was a
heavy inflammatory response at the tumour edge, the disease-
specific survival time tended to be longer. We were unable to
detect human papilloma virus in any of the biopsies analysed.
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Table 1 The disease-specific 75th percentile survival times (months) and
range for patient-related prognostic factors in a series of 105 patients with
cancer of the tongue
Factors (n) 75th percentile Range P
survival time
Gender 0.94
Female (60) 19 (2–43)
Male (45) 17 (3–91)
Age group 0.02
44 yrs and under (12) >60b
45–65 yrs (48) 22 (3–91)
over 65 yrs (45) 13 (2–43)
Socio-economic statusa 0.31
Low (71) 19 (2–91)
High (21) >60b
Domicile 0.66
Urban (68) 19 (3–91)
Rural (37) 17 (2–32)
Smoking* 0.49
No (38) 91 (6–91)
Yes (49) 32 (5–32)
Alcohol consumptiona 0.05
None, seldom, moderate (54) >60b
Heavy (15) 12 (3–17)
aCalculated for those with data available. bThe disease-specific survival rate
was over 75%
Table 2 The disease-specific 75th percentile survival times (months) and
range for clinical prognostic factors in a series of 105 patients with cancer of
the tongue
Factors (n) 75th percentile Range P
survival time
Clinical stagea 0.0001
I (14) 36 (14–91)
II (30) >60b
III (41) 19 (8–43)
IV (16) 5 (3–32)
Carcinoma spread outside 0.04
the tongue
No (82) 31 (2–91)
Yes (23) 12 (3–32)
Size of the carcinomaa 0.38
20 mm or under (20) 91 (8–91)
21–40 mm (62) 17 (2–32)
over 40 mm (20) 12 (4–22)
Neck nodes at the time of diagnosisa 0.25
No (61) 31 (2–91)
Yes (43) 14 (3–32)
Appearance of the carcinomaa 0.93
Exophytic (32) >60b
Ulcerative/crater (34) 22 (9–32)
aCalculated for those with data available. bThe disease-specific survival rate
was over 75%
Table 3 The disease-specific 75th percentile survival times (months) and
range for histopathological prognostic factors in a series of 105 patients with
cancer of the tongue
Factors (n) 75th percentile Range P
survival time
Grade 0.59
Well differentiated (44) 29 (2–36)
Moderately differentiated (40) >60a
Poorly differentiated (3) 16 (16–17)
Malignancy score 0.44
5–10 (38) 43 (6–43)
11–15 (47) 22 (3–32)
16–20 (5) 14 (14–16)
Tumour angiogenesis 0.27
4.7 vessels and under (17) 17 (8–22)
4.8–8.4 vessels (31) 31 (6–91)
8.5 vessels and over (18) >60a
Inflammatory response 0.61
Light (12) 12 (8–14)
Moderate (47) 22 (4–91)
Heavy (38) >60a
Nerve invasion 0.35
No (49) 29 (5–43)
Yes (7) >60a
Apoptosis 0.90
0.6 and under (14) 16 (8–16)
0.7–1.3 (25) 91 (4–91)
1.4 and over (16) 22 (3–22)
Overexpression of p53 protein 0.90
– (37) 19 (6–32)
+ (26) 22 (4–91)
++ (22) 36 (3–36)
aThe disease-specific survival rate was over 75%.Interaction between demographic, clinical and
histopathological factors
As shown in Figure 1, several demographic and histopathological
factors were significantly related to the clinical stage at the time of
diagnosis. We found that male sex, older age, smoking and heavy
use of alcohol correlated significantly with the stage. Furthermore,
it appeared that a low microvessel density, a high malignancy
score of the carcinoma, a heavy inflammatory response at the edge
of the carcinoma, increased apoptosis and an absence of overex-
pressed p53 protein correlated significantly with the clinical distri-
bution of the carcinoma. In contrast, there were no statistically
significant correlations between any of the demographic and
histopathologic factors studied.
Prognostic factors in stage I–II carcinomas
Patient’s age over 65 years, a high malignancy score (16–20
points) and an absence of the overexpressed p53 protein signifi-
cantly shortened the mean disease-specific survival in stage I–II
carcinomas (Table 4). The findings were similar, although not
statistically significant, when the prognostic factors for recurrence
free times were determined (data not shown).
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Figure 1 Statistically significant (P ≤ 0.05, chi-square analysis) interactions
between demographic, clinical and histopathological factors marked with
arrows in a series of 105 patients with cancer of the tongue
Table 4 The disease-specific 75th percentile survival times (ST) in months and range according to patient-related and histopathologic
prognostic factors in stage I–II carcinomas and in stage III–IV carcinomas in 101 patients with cancer of the tongue (stage not available for four
patients)
Stage I–II carcinomas Stage III–IV carcinomas
(n) ST (range) P (n) ST (range) P
All patientsa (44) 91 (6–91) (57) 14 (3–43)
Gender 0.79 0.70
Female (27) >60b (30) 19 (5–43)
Male (17) 31 (6–91) (27) 12 (3–17)
Age group 0.03 0.62
65 yrs and under (24) >60b (32) 14 (3–22)
over 65 yrs (20) 29 (6–36) (25) 13 (5–43)
Smoking 0.23 0.09
No (21) 36 (6–91) (17) >60b
Yes (20) >60b (28) 16 (5–32)
Alcohol consumption 0.27 0.003
None–moderate (30) 91 (6–91) (23) >60b
Heavy (5) >60b (10) 12 (3–17)
Grade 0.87 0.49
Well-differentiated (24) 36 (6–36) (19) 19 (5–22)
Moderately diff. (16) >60b (21) >60b
Poorly differentiated (3) 16 (16–17)
Malignancy score 0.05 0.84
5–10 (20) >60b (18) 43 (8–43)
11–15 (17) >60b (27) 17 (3–32)
16–20 (3) 14 (14–16) (2) >60b
Angiogenesis 0.16 0.09
Under 8.5 vessels (24) 31 (6–91) (22) 17 (9–22)
8.5 vessels and over (7) >60b (10) >60b
Inflammatory response 0.32 0.07
Light (3) >60b (7) 9 (8–14)
Moderate or heavy (40) 91 (6–91) (43) 22 (3–43)
Apoptosis 0.24 0.95
Under 1.4 (16) 91 (16–91) (21) 17 (5–17)
1.4 and over (6) 17 (6–17) (9) 22 (3–22)
Overexpression of p53 protein 0.05 0.49
– (16) 17 (6–29) (21) 19 (9–32)
+–++ (21) >60b (25) 17 (3–43)
aP for the difference between stage I–II and stage III–IV carcinomas was 0.01. bThe disease-specific survival rate was over 75%Prognostic factors in stage III–IV carcinomas
Heavy use of alcohol was significantly related to a poorer prog-
nosis in stage III–IV carcinomas (Table 4). Furthermore, smoking,
low or moderate tumour angiogenesis and a slight inflammatory
response at the edge of the carcinoma tended to correlate with a
poor prognosis, even though the correlation was not significant.
Again, similar findings were achieved when the prognostic factors
for recurrence-free times were determined (data not shown).
DISCUSSION
We analysed the relative importance of demographic, clinical and
histopathological factors in a population-based study of 105
tongue SCC patients. SCC of the tongue is the most common intra-
oral malignancy and is usually detected at a relatively early stage.
In the present patient population, however, there were 57 (56%)
patients with stage III–IV carcinomas. The prognosis of tongue
cancer is better than the prognosis of head and neck SCCs in
general. The prognostic importance of the TNM stage was once
again confirmed by the present findings. It was clearly shown that
the patients with TNM Stage IV carcinomas had a significantly
poorer prognosis than the patients with smaller and more localized
tumours. One must remember, however, that in the present patient
material the treatment was planned according to the TNM stage.
The result confirms the findings of several previous studies
(Ghouri et al, 1993; Bundgaard et al, 1996; Janot et al, 1996).
Particularly local spread outside the tongue rather than spread 
to regional lymph nodes was significantly related to a poor
prognosis.
It was noted that several demographic and histopathological
factors were significantly related to the clinical distribution of the
carcinoma. From a clinical point of view, it is of great interest to
find out the most important prognostic factors in stage I–II cases.
Patient’s older age, a high Bryne’s malignancy score and an
absence of overexpressed p53 protein predicted poorer prognosis
in stage I–II carcinomas. In the case of stage III–IV carcinomas,
heavy use of alcohol was significantly associated with a short
survival time. Since the overall survival of the disease was good,
63%, median survival times could not be calculated. Instead, we
used 75th percentile survival times and ranges, which were more
appropriate here.
The patient’s older age significantly shortened the disease-
specific survival time in the present study. The result is in accor-
dance with a previous study, where head and neck SCC patients
aged over 60 years had a significantly poorer prognosis than
younger patients (Janot et al, 1996). However, contradictory data
also exist. Friedlander et al (1997) noted that the patient’s younger
age was associated with aggressive tumour behaviour in tongue
cancers.
The prognostic value of Bryne’s malignancy score in oral
cancers has been shown earlier by other authors (Piffkò et al,
1997). The present study is the first to our knowledge to establish
the prognostic significance of the malignancy score, specifically in
stage I–II tongue cancers. There were, however, only three stage
I–II carcinomas in the group with the highest malignancy scores.
This might reflect the less aggressive nature of tongue cancer
compared to the majority of head and neck cancers. In a study by
Högmo et al (1999) of stage I tongue cancer patients no correlation
between the malignancy score and regional recurrence of the
disease was found. In that particular study, however, Bryne’s
malignancy score was analysed factor by factor and not as a total
score. It is thus impossible to conclude whether the score itself
would have had a prognostic value.
According to the present study it seems that an absence of the
overexpressed p53 leads to a poorer prognosis in stage I–II carci-
nomas. The finding is quite the opposite compared to a recent
Swedish study, where the presence of p53 predicted regional
recurrence in early stage tongue carcinomas (Högmo et al, 1999).
According to Leedy et al (1994), however, p53 did not have any
prognostic value in T1 and T2 tongue carcinomas. Similarly, the
study by Gluckman et al (1997) revealed no association between
the presence of p53 and tumour aggressiveness. In the present
study the overexpression of p53 protein was determined with
immunohistochemical (IHC) staining. False negative results may
occur when the PCR method is used, as it tests only certain exons
(5–8) of the protein, leaving the mutations possibly occurring in
other exons undetected (Soussi et al, 1994). Saunders et al (1999)
performed full-length gene sequencing and IHC staining to deter-
mine p53 in laryngeal carcinomas. Nevertheless, they did not find
a correlation between the presence of p53 and the recurrence rate
of carcinomas.
There was a trend to suggest that a heavy angiogenesis is related
to a good prognosis in stage III–IV carcinomas, contradicting the
earlier findings (Gasparini et al, 1993; Shpitzer et al, 1996), but
agreeing with the study by Janot et al (1996), where head and neck
SCC patients with higher microvessel counts had better two-year
overall survival rates and lower rates of locoregional failures and
metastasis. The number of microvessels was small in the present
study compared to the previous studies (Leedy et al, 1994;
Gluckman et al, 1997). This was most probably due to the fact that
the microvessels were counted within the carcinoma and not in the
‘hot spot’ area, nor were single stained cells considered microves-
sels. None of the staining methods presently in use (factor VIIIAg,
CD-31 and CD-34) are able to distinguish between neovascular-
ization and the vessels that existed before tumour development.
Moreover, it has been suggested that due to the abundant vascu-
larity of the tongue and the oral cavity, carcinomas of this region
might be less dependent on neovascularization for growth and
metastasis (Gleich et al, 1997).
Human papillomavirus (HPV) was not found in a single case in
this patient population. This was quite surprising in view of how
much published data are available concerning the correlation
between the expression of HPV and oral SCC. However, there are
also some previous studies with similar results (Zeuss et al, 1991;
Matzow et al, 1998). In a recent study by Pintos et al (1999) on
upper aerodigestive tract neoplasms, HPV was detected in three
out of 26 oral SCCs. The authors noted that the HPV detection rate
was higher for pharyngeal carcinomas than for tumours of the
mouth or the larynx. We used two sensitive methods to detect
HPV, PCR and in situ hybridization, which makes our results reli-
able. In the analysis PCR by β -actin primers gave a positive result
in every sample. This indicates that the amplification of genomic
DNA was successful and false negative results were excluded.
Furthermore, the detection of HPV was done with exactly similar
techniques as in the study by Soini et al (1996), where HPV DNA
was found in 30% of the lung carcinoma samples studied.
As a conclusion, according to the present study, the TNM stage
and particularly the local spread of the carcinoma at the time of
diagnosis significantly correlated with the disease-specific
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survival time in patients with SCC of the tongue. In stage I–II
carcinomas the patient’s older age (> 65 years), a high malignancy
score and an absence of overexpressed p53 protein had a profound
effect on disease-specific survival. According to this study, small,
localized carcinomas in such cases may require more aggressive
treatment.
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